Skip to main content
    C

    Cogent Biosciences Inc (COGT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.44
    -1.12 (-3.92%)

    Market Cap: $4.97B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cogent Biosciences Inc (COGT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cogent Biosciences are Legend Biotech (LEGN), CG Oncology, Inc. Common stock (CGON) and Crispr Therapeutics AG (CRSP). By market cap, Cogent Biosciences ranks 7th of the 13 companies on this page; Praxis Precision Medicines (PRAX) is the largest at $9.17B.

    Peer Comparison

    COGT's ROIC of -43.4% is below the peer median of -25.2%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cogent Biosciences (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    CG Oncology, Inc. Common stock (CGON)$6.65BN/AN/A0.0%-21.1%-3.7%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Celcuity LLC (CELC)$3.15BN/AN/A0.0%-25.2%0.0%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Edgewise Therapeutics Inc (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Ligand Pharmaceuticals Incorporated (LGND)$6.18B66.5x23.7x20.3%0.1%-31.8%0.00%
    Peer median$4.56B166.5x23.7x0.0%-25.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cogent Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    CG Oncology, Inc. Common stock (CGON)
    CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070...
    CGON competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Celcuity LLC (CELC)
    Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States.
    CELC competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Edgewise Therapeutics Inc (EWTX)
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.
    EWTX competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    Ligand Pharmaceuticals Incorporated (LGND)
    Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover...
    LGND competitors

    Frequently Asked Questions About COGT

    Who are Cogent Biosciences' main competitors?

    The companies most similar to Cogent Biosciences include Legend Biotech (LEGN), CG Oncology, Inc. Common stock (CGON), Crispr Therapeutics AG (CRSP), Beam Therapeutics (BEAM) and PTC Therapeutics (PTCT), listed from the closest match.

    Who is Cogent Biosciences' biggest competitor?

    Praxis Precision Medicines (PRAX) is the largest of the similar companies at $9.17B; Legend Biotech (LEGN) is the closest match by business profile, size, sector and industry.

    How does COGT stock compare with its competitors?

    COGT's net margin is 0.0% against a peer median of 0.0%.

    Which of Cogent Biosciences' competitors pays a higher dividend?

    Cogent Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cogent Biosciences bigger than its competitors?

    No. Cogent Biosciences is 7th by market cap among the 13 companies on this page; the largest is Praxis Precision Medicines (PRAX) at $9.17B.